...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New PP on Aug 13

It appears that KD stepped up for almost another 50,000 units. Since the deal was done in USD but the 45-106F1 form has to report in CAD, it appears that the exact price was $2.00 USD/unit with the warrants exerciseable at $3.00 USD.

Share
New Message
Please login to post a reply